Concepedia

Benjamin Miron

BM

8

Publications

336

Citations

8

H-Index

2008

Active since

Affiliations

Fox Chase Cancer Center(Current)

Memorial Sloan Kettering Cancer Center

Thomas Jefferson University

Benjamin Miron is an author at Fox Chase Cancer Center specializing in medicine, oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2008–2023

8

Publications

8

A phase 2 trial of erlotinib in patients with previously treated squamous cell and adenocarcinoma of the esophagus

David H. Ilson, David P. Kelsen, Manish A. Shah et al. · Cancer · 2010 · 111 citations · Full text

Defects in DNA Repair Genes Confer Improved Long-term Survival after Cisplatin-based Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer

Benjamin Miron, Jean Hoffman‐Censits, Fern Anari et al. · European Urology Oncology · 2020 · 76 citations · Full text

, , +7

Subclonal Therapy by Two EGFR TKIs Guided by Sequential Plasma Cell-free DNA in EGFR -Mutated Lung Cancer

Nir Peled, Laila C. Roisman, Benjamin Miron et al. · Journal of Thoracic Oncology · 2017 · 50 citations · Full text

, , +7

Clinical and Functional Characterization of Atypical <i>KRAS</i> / <i>NRAS</i> Mutations in Metastatic Colorectal Cancer

Jonathan M. Loree, Yucai Wang, Muddassir Syed et al. · Clinical Cancer Research · 2021 · 36 citations · Full text

Comparative Effectiveness of Front-Line Ipilimumab and Nivolumab or Axitinib and Pembrolizumab in Metastatic Clear Cell Renal Cell Carcinoma

Kevin Zarrabi, Elizabeth A. Handorf, Benjamin Miron et al. · The Oncologist · 2022 · 25 citations · Full text

Rows per page

1–5 of 8